Delivery Order SPE2DB22D2211-SPE2DB25FRVUW

Award Date 4/23/25
Potential Completion Date 4/24/25
Potential Value $38K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $17,986.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Biktarvy 50-200-25 mg tablets, a brand-name HIV medication. This is a Firm Fixed Price delivery order contract with a period of performance through May 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The $12,500.73 firm fixed price delivery order is for the supply of Biktarvy 50-200-25 mg tablets, a brand name HIV medication, to support military treatment programs and facilities. The award is associated with a single-award indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp that has a...
This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $42,417.77, is for the supply of Biktarvy 50-200-25 mg tablets, a medication used in the treatment of HIV. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,496.48, is for the delivery of the drug Biktarvy 50-200-25 mg tablets, a specialty medication used in the treatment of HIV. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,865.48 firm fixed-price delivery order is for the supply of Biktarvy 50-200-25 mg tablet, a medication used to treat HIV. The contract has a performance period ending on May 15, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,675.33 firm fixed price delivery order is for the supply of Biktarvy 50-200-25 mg tablets, a specialty medication used for the treatment of HIV. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Biktarvy 50-200-25 mg tablets, a medication used to treat HIV. The contract has a ceiling value of $53,868.66 and a period of performance through April 24, 2025. This award is not set aside and represents open competition. Amerisourcebergen Drug Corp is the prime...
This is a $31,892.68 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Biktarvy 50-200-25 mg tablets, a medication used to treat HIV. The contract has an ultimate completion date of April 17, 2025 and is not a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $40,333.15, is for the delivery of the drug Biktarvy, a medication used to treat HIV. The contract is a Firm Fixed Price Delivery Order with a period of performance through May 23, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $16,696.76, is for the delivery of Biktarvy 50-200-25 mg tablets, which are used to treat HIV. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of May 29, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB25FRVUW
    Delivery Order

This federal contract award, valued at $38,483.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Biktarvy 50-200-25 mg tablet, a HIV medication. The contract is a firm-fixed price delivery order with an ultimate completion date of April 24, 2025. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 7/23/25, 9:48 AM